#Amniotic Membrane Market

[adityarana1687-blog]

Amniotic Membrane Market Size To Reach $8.50 Billion By 2030

The global amniotic membrane market size is expected to reach USD 8.50 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Global rise in the number of trauma and burn cases, surgeries, and increasing cognizance regarding various benefits offered by amniotic membrane-based products are factors increasing their demand. Amniotic membrane has pain-reducing properties, which may lead to the increased adoption of these tissue-based products in surgical wounds and ophthalmology.

Also, rising expenditure in R&D in the field of stem cells and regenerative medicine and the rising number of surgeries being performed are some of the key factors anticipated to augment the market growth. The global market is expected to gain potential owing to a wide range of product applications in ophthalmology, skin, brain, and head & neck, genitourinary tract, as well as other surgical procedures. In addition, the rise in amniotic membrane-based transplantations across the globe is predicted to fuel the overall market growth. Moreover, rising awareness regarding the product benefits among healthcare professionals as well as individuals is estimated to boost the demand over the forecast years.

However, the dearth of skilled professionals is expected to impede market growth. Amniotic membrane-based products are most commonly used in the treatment of various areas, such as venous, pressure, and diabetic foot ulcers, ophthalmology, surgeries, and also in the management of chronic wounds. Moreover, with increasing research in the field of stem cell research and regenerative medicine, various research and academic institutes are engaged in a study to facilitate the usage of these products for other applications.

Request a free sample copy or view report summary: Amniotic Membrane Market Report

Amniotic Membrane Market Report Highlights

The cryopreserved amniotic membrane segment held the largest revenue share of more than 50.0% in 2023 owing to the high effectivity and preservation of histological and biological properties in these membranes

The surgical wounds segment accounted for the maximum revenue share of 36.7% in 2023 due to the increased volume of surgical procedures and wide product usage in surgical applications

Specialty clinics are anticipated to gain the highest market share by 2030 due to the increasing number of cosmetic and reconstructive surgeries being performed globally

North America dominated the market in 2023 with a revenue share of 31.7% owing to the existence of a large number of major players and the high incidence of chronic and infectious diseases

Asia Pacific is expected to grow at the fastest CAGR of 14.5% during the forecast period due to the high population coupled with the rising chronic diseases and burn incidences

Amniotic Membrane Market Segmentation

Grand View Research has segmented the global amniotic membrane market on the basis of product, application, end-use, and region:

Amniotic Membrane Product Outlook (Revenue, USD Million, 2018 - 2030)

Cryopreserved Amniotic Membrane

Dehydrated Amniotic Membrane

Amniotic Membrane Application Outlook (Revenue, USD Million, 2018 - 2030)

Surgical Wounds

Ophthalmology

Others

Amniotic Membrane End Use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Research Institutes and Academic Institutes

Amniotic Membrane Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List Of Key Players in the Amniotic Membrane Market

Alliqua BioMedical Inc.

Amnio Technology, LLC

Applied Biologics LLC

Human Regenerative Technologies, LLC

DermaSciences

Katena Products, Inc.

MiMedx Group Inc.

Skye Biologics, Inc.

Amniox Medical Inc.

Organogensis, Inc.

[chetanagp]

Amniotic Membrane Market is expected to grow at a CAGR of 9.65% during the forecast period and the market size is expected to reach nearly US$ 2.71 Bn by 2029.

[tritonmarketresearch]

AM Potential in Tissue Engineering to Drive Amniotic Membrane Market’s Growth

Triton Market Research presents the Global Amniotic Membrane Market report sectioned by End-users (Specialized Clinics, Hospitals, Ambulatory Surgical Wounds, Research Centers & Laboratories), Application (Ophthalmology, Surgical Wounds, Other Applications), Type (Lyophilization Amniotic Membrane, Cryopreserved Amniotic Membrane), and by Geography (Latin America, Asia-Pacific, Europe, North America, Middle East and Africa). The report also discusses the Market Summary, Industry Outlook, Impact of COVID-19, Key Insights, Porter’s Five Forces Analysis, Market Attractiveness Index, Vendor Scorecard, Key Market Strategies, Drivers, Challenges, Opportunities, Competitive Landscape, Research Methodology & Scope, Global Market Size, Forecasts & Analysis (2022-2028).

Based on Triton’s research report, the global amniotic membrane market is expected to grow at a CAGR of 7.01% during the forecast period 2022-2028.

Request Free Sample Report:

https://www.tritonmarketresearch.com/reports/amniotic-membrane-market#request-free-sample

 The amniotic membrane refers to the innermost layer of the fetal placenta. It is used for various treatments, including ocular surface repair and tissue transplantation.

Amniotic membrane or amnion has shown potential to be used as a scaffold in numerous tissue engineering applications. In this regard, the genipin-crosslinked group (clAM) of human amniotic membranes has better biostability and biocompatibility. Therefore, the application of amnion in tissue engineering creates novel growth opportunities for the amniotic membrane market globally.

On the contrary, the use of an amniotic membrane is limited as its use in treating lung and other organ damages is still under research. Hence, the limited use of amnion restricts the amniotic membrane market’s global growth.

The Asia-Pacific region is anticipated to witness the fastest growth over the forecast period. The region’s robust growth is mainly owing to the growing applications of amnion across China, India, and South Korea. In China, the rising number of accidents and cosmetic surgery trends have increased the application of AM for various treatments. The demand for eye surgeries to prevent glasses is another reason supporting amniotic membrane use in eye treatments. Therefore, as stated above, all these factors drive the amniotic membrane market on a progressive path across the region.

The notable companies in the amniotic membrane market include Sky Biologics LLC, Human Regenerative Technologies, Labtician Ophthalmics Inc, Amino Technology LLC, Surgenix LLC, Organogenesis, MiMedx, Amniox Medical Inc, Celularity Inc, Integra Lifescience Corp, Bio Tissue Inc, Smith and Nephew Plc, Surgilogix LLC, and Katena Products Inc.

The market is heavily fragmented; however, it is expected to witness significant development over the forecast period. The barrier of entry is high as players require high capital investment in research, clinical trials, and more. Hence, the threat of new players is low. Further, since the market is emerging with no product differentiation, innovation and research are expected to drive the competition among existing players. This indicates the competition levels to be moderate over the forecast period.

 Contact Us:

sales@tritonmarketresearch.com

Phone: +44 7441 911839

[reserchnester-blog]

Amniotic Membrane Market Report & Analysis

The global amniotic membrane market is estimated to garner a revenue of USD 3 Billion by the end of 2035 by growing at a CAGR of ~5% over the forecast period, i.e., 2023 – 2035.

[healthcarehubhh]

The Global Amniotic Membrane Market will grow at highest pace owing to rising aging population.

Amniotic Membrane or amnion refers to the innermost layer of the placenta. It acts as a physical barrier between the fetus and the mother's uterus. Amniotic membrane finds wide application in wound healing and surgical reconstruction owing to its anti-inflammatory, anti-scarring, and anti-angiogenic properties. It is used in treatments involving burns, skin injuries, ophthalmic defects, and chronic non-healing ulcers. The growing geriatric population suffering from chronic diseases and wounds has increased the demand for amniotic membrane products in wound management. The Global Amniotic Membrane Market is estimated to be valued at US$ 3.62 Bn in 2024 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the Amniotic Membrane market are Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical. The growing aging population and increase in chronic wounds has augmented the demand for amniotic membrane products. Technological advancements such as development of micronized and acellular amniotic membranes formulations have expanded the application scope of amniotic membranes. Market Trends Cryopreservation of Amniotic Membranes - Cryopreservation allows for long-term storage of amniotic membranes at sub-zero temperatures while maintaining viability and key properties. This enables stockpiling and just-in-time delivery of amniotic membranes to clinics and hospitals. Micronization of Amniotic Membranes - Micronization is the process of comminuting amniotic membranes into micron-sized powder. This improves handling, storage, and delivers concentrated growth factors effectively to target sites. Micronized amniotic membranes have applications in wound healing and regenerative medicine. Market Opportunities Rising Aging Population - The growing geriatric population prone to chronic wounds, burns, and non-healing injuries will drive the demand for amniotic membrane products in wound management over the forecast period. Expanding Applications in Regenerative Medicine - Increased research on regenerative potential of amniotic membranes is extending their use in treatment of degenerative ocular surface diseases, lower urinary tract conditions, musculoskeletal disorders thereby opening new opportunities. Impact of COVID-19 on Amniotic Membrane Market: The COVID-19 pandemic posed significant challenges to the amniotic membrane market. During the early phases of the pandemic, restrictions on non-essential medical procedures led to supply chain disruptions and uncertainties around product availability. Manufacturers faced challenges in sourcing raw materials and maintaining continuous production due to lockdowns and social distancing measures. Movement restrictions also impacted the delivery of products to customers. The focus of healthcare resources on critical COVID-19 patients resulted in delays and postponements of other medical procedures that utilize amniotic membrane products. This adversely affected market demand in the short term.

[stickyleadybloger]

https://www.xaphyr.com/blogs/236348/Amniotic-Membrane-Market-Outlook-Key-Growth-Factor-Analysis-and-Competitive

Amniotic Membrane Market Outlook, Key Growth Factor Analysis and Competitive Landscape 2030

[deshpandeisha]

Introduction to Amniotic Products: An Overview of Uses and Benefits

The amniotic products market is a rapidly growing industry that is revolutionizing the healthcare sector. These products are derived from the amniotic membrane and fluid, which is a protective sac that surrounds the fetus during pregnancy. The global amniotic products market size was USD 2.85 Billion in 2022 and is expected to register a steady revenue CAGR of 14.50% during the forecast period, according to latest analysis by Emergen Research.

The overview of the amniotic products market is promising, with an increasing adoption of these products across various healthcare sectors. The market is primarily driven by factors such as the growing demand for regenerative medicine, increasing use of amniotic products in wound care, and rising incidence of chronic diseases.

One of the major drivers of the market is the growing demand for regenerative medicine. Amniotic products have regenerative properties and can be used for tissue repair and regeneration. They are used in a variety of applications such as wound healing, orthopedics, and ophthalmology.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1868

Competitive Terrain:

The global Amniotic Products industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Amnio Technology, LLC., BioTissue, Human Regenerative Technologies, LLC, Corza Ophthalmology, MIMEDX, Integra LifeSciences, Skye Biologics Holdings, LLC, CCD Laboratory, VIVEX Biologics, Inc., Merakris Therapeutics, Inc

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Amniotic Products market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Amniotic Products market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Amniotic Products market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1868

Market Segmentations of the Amniotic Products Market

This market is segmented based on Types, Applications, and Regions. The growth of each segment provides accurate forecasts related to production and sales by Types and Applications, in terms of volume and value for the period between 2022 and 2030. This analysis can help readers looking to expand their business by targeting emerging and niche markets. Market share data is given on both global and regional levels. Regions covered in the report are North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Research analysts assess the market positions of the leading competitors and provide competitive analysis for each company. For this study, this report segments the global Amniotic Products market on the basis of product, application, and region:

Segments Covered in this report are:

Type Outlook (Revenue, USD Billion; 2019-2032)

Amniotic Membranes

Amniotic Suspensions

Application Outlook (Revenue, USD Billion; 2019-2032)

Wound Care

Orthopedics

Ophthalmology

Other Applications

End-use Outlook (Revenue, USD Billion; 2019-2032)

Hospitals & Ambulatory Surgical Centers (ASCs)

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/amniotic-products-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1868

[chetanagp]

Amniotic Membrane Market is expected to grow at a CAGR of 9.65% during the forecast period and the market size is expected to reach nearly US$ 2.71 Bn by 2029.

[tritonmarketresearch]

Amniotic Membrane Market: Significance & Global Performance

Amniotic membrane or amnion, a thin membrane on the inner side of the fetal placenta and composed of the epithelium, has emerged as an ideal source for tissue transplantation. Moreover, amnion has an array of biological properties, making it attractive for use in various surgical procedures, including ocular surface reconstruction and tissue engineering.

The advancements in anatomy have triggered significant investments in research and development of amniotic membrane applications. While AM has shown beneficial results in burn injuries, the upsurge in R&D investments has increased its use in eye surgery, cell therapy, stem cell research, and more, boosting the amniotic membrane market growth prospects.

In fact, the identification of new stem cells has increased the membrane’s potential, making it ideal for developing regenerative medicines. For instance, Organogenesis Holdings Inc, a leading regenerative medicine company, gained approval from the US FDA for ReNu, a cryopreserved amniotic suspension allograft, to manage symptoms related to knee osteoarthritis.

Amniotic Membrane Market - Global & Regional Trends

As per estimates, the global amniotic membrane market will display revenue growth at a CAGR of 7.01% during the forecast period 2022-2028.

Considering the evolving healthcare sector, the amniotic membrane market is expected to witness tremendous growth in the Asia-Pacific nations. Estimates suggest that approximately half a billion people in the region will be 65 or older by 2025. This change in demographics, in addition to a shift in consumer expectations, will widen the market’s scope. In this regard, the growing demand for chronic care management will expand amnion application in ophthalmology, burn injuries, and cosmetic surgeries, among others.

Additionally, amniotic membrane transplantation has gained momentum in various conjunctival and corneal diseases, signaling opportunistic growth for players in the APAC region. Considering its growth in North America, amnions have proven advantageous in treating limbal stem cell deficiency, providing support and protection to transplanted limbal tissues and stem cells. Recently, in Canada, numerous techniques have been developed to dehydrate amnion while preserving the wound-healing properties to formulate a temperature-stable allograft.

Furthermore, the United Kingdom is the center of research and development of amniotic membrane applications in Europe. Several hospitals, such as NuVision, have gained expertise in providing AM treatments. Amniotic membrane treatments are gaining center stage across the nation, given the technological advancements. For instance, in November 2021, several ophthalmologists shared their innovations of AM application in treating ocular surface conditions through a webinar sponsored by NuVision Biotherapies Ltd.

Market by Application – Expert Outlook

Surgical Wounds: Human amniotic membrane has been used for treating acute and chronic wounds, decreasing infection and pain while accelerating the healing time. The surgical wound segment dominates the overall market and is expected to maintain its stronghold till 2028. Although a plethora of wound dressings are available, chronic wounds remain a major medical concern. As a result, chronic wounds awareness programs largely support amnion application. For instance, the Wound Healing and Hyperbaric Center at Carteret Health Care, a Healogic Network member, is engaged in raising awareness of chronic wounds, providing advanced therapies.

Ophthalmology: The rise in chronic and infectious diseases has resulted in a global rise in surgeries, boosting the market’s potential. Amniotic membrane is rapidly used in ophthalmic surgeries to initiate faster recovery and decrease inflammation. Amnion has become crucial in eye treatments, given its anti-scarring and anti-inflammatory properties. For instance, Bio Tissue Inc offers AmnioGraft to treat ocular surface indications like corneal ulcers, dry eye, chemical burns, etc. Besides, AM is highly preferred in developing regions since it is cheaper than allografts.

Competitive Analysis

For any company, acquisitions and agreements ensure expansion in business footings. Acquisitions, for instance, are quicker, cheaper, and less risky compared to other methods to extend volume sales. On the other hand, agreements are crucial to eliminating disagreements, confusion, or changes that may transpire during the course of the business period.

Notable acquisitions and agreements that support the market’s development:

In February 2021, Katena Products Inc, a leading provider of premium ophthalmic instruments and devices, announced the acquisition of ASICO LLC to expand the ophthalmic surgical product line and lead in the innovation of new products.

Integra LifeSciences Corporation, in January 2021, acquired ACell Inc and its proprietary MatriStem UMB to offer comprehensive wound management solutions.

Celularity Inc and Oncternal Therapeutics Inc entered into a research partnership in September 2021 to examine placental-derived cellular treatments.

Celularity also collaborated with Imugene Ltd in August 2021 to employ Imugene’s CD19 oncolytic virus technology and its CD19 CYCART-19 to remedy solid tumors.

In Conclusion,

The amniotic membrane market has shown rapid and promising results in healing damaged tissues. From chemical burns to ulcers to the cornea, amnions have emerged as suitable membranes in wound care management. This indicates that the use of AM in medicine and therapies is expanding in various branches of medicine.